540204 — Eiko Lifesciences Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹725.28m
- IN₹664.04m
- IN₹279.29m
- 24
- 25
- 33
- 14
Annual cashflow statement for Eiko Lifesciences, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | C2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 1.3 | 8.33 | 9.42 | 10.3 | 9.84 |
| Depreciation | |||||
| Non-Cash Items | -0.063 | -2.7 | -1.78 | -6.08 | -0.397 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.85 | -14.5 | -90.5 | 31.7 | -86.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 7.71 | -8.25 | -77.3 | 42.2 | -70.8 |
| Capital Expenditures | — | 0 | -1.55 | -2.25 | -3.46 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -6.48 | -29.4 | 7.47 | 22.2 | -2.02 |
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -6.48 | -29.4 | 5.92 | 20 | -5.49 |
| Financing Cash Flow Items | -0.683 | -0.878 | -4.64 | -1.5 | -1.42 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -1.3 | 78.1 | 32.8 | -47 | 204 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.074 | 40.5 | -38.5 | 15.2 | 127 |